CIK 0001816590 · Non-accelerated filer<br>Smaller reporting company
COMPASS Pathways plc
Sign in to watch- Ticker
- CMPS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 1-716-676-6461
- Business address
- 3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM, CHESIRE, United Kingdom, WA14 2DT
- Former names
- Compass Rx Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-01 | Nath Kabir Chief Executive Officer | Shares withheld for taxes | −5,794 | $8.95 | $52K | 69,406 |
| 2023-08-01 | Nath Kabir Chief Executive Officer | Shares withheld for taxes | −5,000 | $8.95 | $45K | 70,200 |
| 2023-08-01 | Goldsmith George Jay Director | Shares withheld for taxes | −1,470 | $8.95 | $13K | 4,271,569 |
| 2023-08-01 | Goldsmith George Jay Director | Shares withheld for taxes | −1,526 | $8.95 | $14K | 4,268,967 |
| 2023-08-01 | Malievskaia Ekaterina Director | Shares withheld for taxes | −1,526 | $8.95 | $14K | 4,268,967 |
| 2023-08-01 | Malievskaia Ekaterina Director | Shares withheld for taxes | −1,470 | $8.95 | $13K | 4,271,569 |
| 2023-08-01 | Jenkins Annalisa Director | Shares withheld for taxes | −161 | $8.95 | $1K | 20,170 |
| 2023-06-02 | McGoldrick Linda Director | Grant or award · Share Option (Right to Buy) | +26,000 | 26,000 | ||
| 2023-06-02 | Riley Wayne Joseph Director | Grant or award · Share Option (Right to Buy) | +26,000 | 26,000 | ||
| 2023-06-02 | McQuade Robert Director | Grant or award · Share Option (Right to Buy) | +26,000 | 26,000 | ||
| 2023-06-02 | Goldsmith George Jay Director | Grant or award · Share Option (Right to Buy) | +39,000 | 39,000 | ||
| 2023-06-02 | Lonngren Thomas Director | Grant or award · Share Option (Right to Buy) | +26,000 | 26,000 | ||
| 2023-06-02 | Jenkins Annalisa Director | Grant or award · Share Option (Right to Buy) | +26,000 | 26,000 | ||
| 2023-06-02 | Norton David Y Director | Grant or award · Share Option (Right to Buy) | +26,000 | 26,000 | ||
| 2023-05-02 | Jenkins Annalisa Director | Shares withheld for taxes | −25 | $7.97 | $199 | 20,331 |
| 2023-05-02 | Malievskaia Ekaterina Chief Innovation Officer | Shares withheld for taxes | −1,526 | $7.97 | $12K | 4,270,493 |
| 2023-05-02 | Malievskaia Ekaterina Chief Innovation Officer | Shares withheld for taxes | −1,470 | $7.97 | $12K | 4,273,039 |
| 2023-05-02 | Goldsmith George Jay Director | Shares withheld for taxes | −1,470 | $7.97 | $12K | 4,273,039 |
| 2023-05-02 | Goldsmith George Jay Director | Shares withheld for taxes | −1,526 | $7.97 | $12K | 4,270,493 |
| 2023-02-02 | Goodwin Guy Chief Medical Officer | Grant or award · Share Option (Right to Buy) | +63,900 | 63,900 |
Page 9 of 12 · 230 trades